1
Clinical Trials associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Cell Therapy Engineering Technology) / RecruitingEarly Phase 1 A Clinical Study to Evaluate the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells Combined With Antiviral Therapy in the Treatment of AIDS Patients With Immune Non-responder
The goal of this clinical trial is to explore the effect of mesenchymal stem cell therapy on immune non-responder patients. The main questions it aims to answer are:
1. Efficacy of human umbilical cord mesenchymal stem cells combined with antiviral therapy in the treatment of AIDS patients with immune non-response.
2. Safety of human umbilical cord mesenchymal stem cells combined with antiviral therapy in AIDS patients with immune non-response.
Participants will receive CD4,CD4/CD8, and RNA viral load tests and will be randomly assigned to either saline or mesenchymal stem cell therapy.
Investigators will evaluate the safety and efficacy of mesenchymal stem cell therapy based on examination results.
100 Clinical Results associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Cell Therapy Engineering Technology)
100 Translational Medicine associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Cell Therapy Engineering Technology)
100 Patents (Medical) associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Cell Therapy Engineering Technology)
100 Deals associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Cell Therapy Engineering Technology)